受强制性开放获取政策约束的文章 - Qian Nie了解详情
可在其他位置公开访问的文章：5 篇
Quantitative contribution of rs75017182 to dihydropyrimidine dehydrogenase mRNA splicing and enzyme activity
Q Nie, S Shrestha, EE Tapper, CS Trogstad‐Isaacson, KJ Bouchonville, ...
Clinical Pharmacology & Therapeutics 102 (4), 662-670, 2017
强制性开放获取政策： US National Institutes of Health
Gene‐specific variant classifier (DPYD‐Varifier) to identify deleterious alleles of dihydropyrimidine dehydrogenase
S Shrestha, C Zhang, CR Jerde, Q Nie, H Li, SM Offer, RB Diasio
Clinical Pharmacology & Therapeutics 104 (4), 709-718, 2018
强制性开放获取政策： US National Institutes of Health
Novel deleterious dihydropyrimidine dehydrogenase variants may contribute to 5‐fluorouracil sensitivity in an East African population
T Elraiyah, CR Jerde, S Shrestha, R Wu, Q Nie, NH Giama, V Sarangi, ...
Clinical Pharmacology & Therapeutics 101 (3), 382-390, 2017
强制性开放获取政策： US National Institutes of Health
Histone H3K27 trimethylation modulates 5-fluorouracil resistance by inhibiting PU. 1 binding to the DPYD promoter
R Wu, Q Nie, EE Tapper, CR Jerde, GS Dunlap, S Shrestha, TA Elraiyah, ...
Cancer research 76 (21), 6362-6373, 2016
强制性开放获取政策： US National Institutes of Health
Chromatin assembly factor 1 suppresses epigenetic reprogramming toward adaptive drug resistance
Z Wang, R Wu, Q Nie, KJ Bouchonville, RB Diasio, SM Offer
Journal of the National Cancer Center 1 (1), 15-22, 2021
强制性开放获取政策： US National Institutes of Health
出版信息和资助信息由计算机程序自动确定